Delivery Order SPE2DB25D3003-SPE2DB25FPWGE

Award Date 4/28/25
Potential Completion Date 4/29/25
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Nucynta 50 mg tablets, a pain management medication, with a ceiling value of $1,225.04 and a period of performance through May 2, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,010.63, is for the delivery of NUCYNTA 50 MG TABLET 100S, a prescription pain medication. The contract has a firm fixed-price pricing type and an ultimate completion date of April 1, 2025. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at $1,586.92, is for the delivery of 4,564,801,711 units of the pharmaceutical product NUCYNTA 50 MG TABLET 100S. The contract has a firm fixed price pricing type and a completion date of June 5, 2024. Amerisourcebergen, a major pharmaceutical distribution company, has been awarded this contract without any set-aside designation,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $1,733.88 contract is for the supply of NUCYNTA 50 MG TABLET 100S, a prescription medication. The delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for a comprehensive range of medical commodities to support military...
This is a $1,330.66 delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation. The contract is for the supply of NUCYNTA 50 MG TABLET 100S, a pharmaceutical product. This delivery order falls under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,194.33, is for the delivery of NUCYNTA ER 50 MG TABLET 60S, a pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of parent company Cencora, Inc. doing business as Amerisourcebergen. The contract, valued at $1,155.92, is for the delivery of 100 units of the pharmaceutical drug NUCYNTA 50 MG TABLET. The delivery order has a completion date of February 2, 2024 and was awarded on February 1, 2024. This delivery order is issued under an indefinite...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,311.84, is for the supply of 100 units of the medication NUCYNTA 50 MG TABLET. The award has an ultimate completion date of June 21, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running...
The U.S. Defense Logistics Agency (DLA) awarded a $5,497.95 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of 4,565,766,357 units of NUCYNTA 100 MG TABLET 100S, a pharmaceutical product, with a period of performance through September 12, 2024. This award is a part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical for delivering a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,727.09, is for the supply of NUCYNTA 75 MG TABLET 100S, a prescription medication. The contract has an ultimate completion date of October 22, 2024 and is a firm fixed-price contract. This contract is not associated with a set-aside program. AmerisourceBergen holds a significant...
  • SPE2DB25D3003
    Indefinite Delivery Contract
  • SPE2DB25D3003-SPE2DB25FPWGE
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,225.04, is for the delivery of 4,568,059,518 units of the pharmaceutical product NUCYNTA 50 MG TABLET 100S. The contract is a firm fixed-price delivery order with an ultimate completion date of April 29, 2025. This contract is not designated as a set-aside and was open to full and open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026 and positions the company as a critical vendor in supporting federal medical procurement needs, particularly for military and veteran healthcare systems.

Generated 7/28/25, 11:08 AM